Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monthly subcutaneous Mircera in anemic kidney transplant recipients
2010-021355-85Phase 3Active
- Sponsor
- CHU Amiens-Picardie
- Start
- Jul 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of Epoetin alfa RB in anaemia (2 cohorts), sponsored by CHU Amiens-Picardie. Primary endpoints: Hemoglobin variability during evaluation period, Hemoglobin correction and 1 more. Started Jul 2010; status: active.
02
Drugs
Epoetin alfa RB
03
Conditions
anaemia
Beyond the preview
Go deeper on 2010-021355-85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021355-85.